glp-1 and eating disorder Experts express alarm that RAs may trigger or worsen disorders. But is there any role they might play in binge eating disorder? how can clinicians protect patients from risk? GLP-1 and Eating Disorders: Risks
Description
The findings carry a specific implication that the medical community has been slow to act on

The GLP-1 Agonist Agents There are now several drug products in this class, also known as incretin-based therapies (see table below)

Practical tips around comfort and technique support better consistency over time

In: Basic & Clinical Pharmacology
Really interesting move from Boots

Finally, combination therapiesincluding GLP-1 receptor agonists paired with agents targeting complementary pathways such as fibroblast growth factor 21 (FGF21) analogues [137]are poised to shape a promising and diverse treatment landscape for MASH
